ScandiEdge

ScandiEdge Therapeutics AB focuses on developing small molecule drugs for digestive system disorders

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceuticals

Model

01Company Overview

ScandiEdge Therapeutics AB focuses on developing small molecule drugs for digestive system disorders.

02Backed By1 investor

03Similar Companies

AT

ArCHitect Therapeutics

Biotech & Life Sciences

→

ET

AB

V

ST

04Startup DNA

6

signals

Sectors
Business Model
Technology